These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35661745)

  • 1. Improved dissolution of an enteric polymer and its amorphous solid dispersions by polymer salt formation.
    Qi Q; Taylor LS
    Int J Pharm; 2022 Jun; 622():121886. PubMed ID: 35661745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
    Indulkar AS; Lou X; Zhang GGZ; Taylor LS
    Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balancing Solid-State Stability and Dissolution Performance of Lumefantrine Amorphous Solid Dispersions: The Role of Polymer Choice and Drug-Polymer Interactions.
    Hiew TN; Zemlyanov DY; Taylor LS
    Mol Pharm; 2022 Feb; 19(2):392-413. PubMed ID: 34494842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Counterions on Dissolution of Amorphous Solid Dispersions Studied by Surface Area Normalized Dissolution.
    Chen Y; Lubach JW; Tang S; Narang AS
    Mol Pharm; 2021 Sep; 18(9):3429-3438. PubMed ID: 34338529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Media Choice Matter When Evaluating the Performance of Hydroxypropyl Methylcellulose Acetate Succinate-Based Amorphous Solid Dispersions?
    Bapat P; Paul S; Thakral NK; Tseng YC; Taylor LS
    Mol Pharm; 2023 Nov; 20(11):5714-5727. PubMed ID: 37751517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congruent Release of Drug and Polymer from Amorphous Solid Dispersions: Insights into the Role of Drug-Polymer Hydrogen Bonding, Surface Crystallization, and Glass Transition.
    Saboo S; Kestur US; Flaherty DP; Taylor LS
    Mol Pharm; 2020 Apr; 17(4):1261-1275. PubMed ID: 32134677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of drug release as a function of drug loading from amorphous solid dispersions: A comparison of five different polymers.
    Saboo S; Moseson DE; Kestur US; Taylor LS
    Eur J Pharm Sci; 2020 Dec; 155():105514. PubMed ID: 32810579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generality of Enhancing the Dissolution Rates of Free Acid Amorphous Solid Dispersions by the Incorporation of Sodium Hydroxide.
    Zhang HJ; Chiang CW; Maschmeyer-Tombs T; Conklin B; Napolitano JG; Lubach JW; Nagapudi K; Mao C; Chen Y
    Mol Pharm; 2024 Jul; 21(7):3395-3406. PubMed ID: 38836777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congruent release of drug and polymer: A "sweet spot" in the dissolution of amorphous solid dispersions.
    Saboo S; Mugheirbi NA; Zemlyanov DY; Kestur US; Taylor LS
    J Control Release; 2019 Mar; 298():68-82. PubMed ID: 30731151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction.
    Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
    Pharm Res; 2016 Oct; 33(10):2445-58. PubMed ID: 27283830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-Dependent supersaturation from amorphous solid dispersions of weakly basic drugs.
    Wang B; Nethercott MJ; Narula A; Hanrahan M; Kuang S; Wenslow RM; Li N
    Pharm Res; 2022 Nov; 39(11):2919-2936. PubMed ID: 34890018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fed- and Fasted-State Performance of Pretomanid Amorphous Solid Dispersions Formulated with an Enteric Polymer.
    Nguyen HT; Van Duong T; Jaw-Tsai S; Bruning-Barry R; Pande P; Taneja R; Taylor LS
    Mol Pharm; 2023 Jun; 20(6):3170-3186. PubMed ID: 37220082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection.
    Yang R; Mann AKP; Van Duong T; Ormes JD; Okoh GA; Hermans A; Taylor LS
    Mol Pharm; 2021 May; 18(5):2066-2081. PubMed ID: 33784104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Buffer pH and Concentration on the Dissolution Rates of Sodium Indomethacin-Copovidone and Indomethacin-Copovidone Amorphous Solid Dispersions.
    Chiang CW; Tang S; Mao C; Chen Y
    Mol Pharm; 2023 Dec; 20(12):6451-6462. PubMed ID: 37917181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular-Level Examination of Amorphous Solid Dispersion Dissolution.
    Faiz Afzal MA; Lehmkemper K; Sobich E; Hughes TF; Giesen DJ; Zhang T; Krauter CM; Winget P; Degenhardt M; Kyeremateng SO; Browning AR; Shelley JC
    Mol Pharm; 2021 Nov; 18(11):3999-4014. PubMed ID: 34570503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Additives on the Physical Stability and Dissolution of Polymeric Amorphous Solid Dispersions: a Review.
    Li J; Wang Y; Yu D
    AAPS PharmSciTech; 2023 Aug; 24(7):175. PubMed ID: 37603110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay of Drug-Polymer Interactions and Release Performance for HPMCAS-Based Amorphous Solid Dispersions.
    Bapat P; Paul S; Tseng YC; Taylor LS
    Mol Pharm; 2024 Mar; 21(3):1466-1478. PubMed ID: 38346390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteric coating of tablets containing an amorphous solid dispersion of an enteric polymer and a weakly basic drug: A strategy to enhance in vitro release.
    Nguyen HT; Van Duong T; Taylor LS
    Int J Pharm; 2023 Jul; 642():123139. PubMed ID: 37311499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissolution Kinetics of Nifedipine-Ionizable Polymer Amorphous Solid Dispersion: Comparison Between Bicarbonate and Phosphate Buffers.
    Sakamoto A; Sugano K
    Pharm Res; 2021 Dec; 38(12):2119-2127. PubMed ID: 34931285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elucidating the effect of crystallization on drug release from amorphous solid dispersions in soluble and insoluble carriers.
    Ojo AT; Ma C; Lee PI
    Int J Pharm; 2020 Dec; 591():120005. PubMed ID: 33132149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.